News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoCor Therapeutics Gets Major Investment


9/7/2007 12:15:52 PM

CHAPEL HILL - NanoCor Therapeutics, a Chapel Hill startup, got a $3.75 million investment from medical-device giant Medtronic to work on a gene-therapy-based treatment for congestive heart failure. If preclinical tests are successful, Medtronic has agreed to invest at least an additional $3.75 million to start tests in humans.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES